U.S. medical aesthetics industry revenue
Aesthetics and med spa
Finance the technology behind modern aesthetics.
Offer financing for aesthetic treatment devices with a program built around your practice customers. We help vendors and buyers coordinate the equipment quote, application, and installation requirements.
01
Market pulse
A growing market with more treatment options.
Research current through August 22, 2026
Reported annual category growth
Medical spa locations counted in 2023
Reported as single-location businesses
The American Med Spa Association describes U.S. medical aesthetics as a $17 billion-plus industry growing by more than $1 billion per year. Its 2024 industry report counted 10,488 medical spa locations in 2023, up from 8,899 in 2022, and found that 81% were single-location businesses.
Demand also spans a wide treatment mix. The American Society of Plastic Surgeons reported more than 28.5 million minimally invasive cosmetic procedures in 2024. That total included approximately 9.9 million neuromodulator injections, 5.3 million hyaluronic-acid filler procedures, 3.7 million skin-resurfacing procedures, and 3.1 million laser skin treatments.
Those figures show category scale, not the likely performance of a specific practice or device. Local competition, clinical oversight, provider credentials, patient acquisition, pricing, utilization, consumables, service, and operating discipline still shape the individual equipment decision.
Medical spa locations, U.S.
8,8992022
10,4882023
Minimally invasive procedures, 2024
9.9MNeuromodulator
5.3MHA filler
3.7MSkin resurfacing
3.1MLaser skin
What the data means for equipment decisions
The category matters. The specific operating decision matters more.
Growth creates more opportunity for equipment sellers, but it also raises the standard for discovery. A device may support replacement, added capacity, a new treatment line, a new location, or a first-time practice launch. Each scenario creates a different operating and financing context.
For an established practice, the conversation may center on replacement timing, treatment mix, capacity, and continuity. For a new service line, the buyer may need to coordinate room readiness, staff training, protocols, marketing, consumables, and a launch calendar. For a startup or new location, the equipment request is one piece of a larger buildout and working-capital plan.
The strongest vendor programs recognize those differences before a buyer provides sensitive information. Financing should support a well-defined equipment decision. It should not turn demand assumptions, treatment outcomes, or projected revenue into promises.
03
Complete scope
The complete equipment investment
Include installation, software, training, and service in the purchase discussion so costs are clear from the start.
- 01
Energy-based platforms, lasers, IPL, RF, ultrasound, and skin-resurfacing systems
- 02
Body-contouring, muscle-stimulation, and skin-tightening platforms
- 03
Imaging, analysis, photography, consultation, and treatment-planning technology
- 04
Applicators, handpieces, accessories, starter consumables, and required disposables
- 05
Delivery, room preparation, electrical or ventilation work, installation, and calibration
- 06
Initial and ongoing training, clinical education, warranty, software, and service
- 07
Any marketing, staffing, licensing, medical-director, or launch costs outside the equipment request
The financing review determines what is eligible under the applicable structure. A complete quote does not mean every item will be included automatically.
Where financing fits
Compare payment options for the full equipment package.
Financing gives the buyer a way to compare an upfront purchase with an obligation paid over time. That can make timing and cash allocation easier to evaluate, but it does not establish whether the device will attract patients, achieve a utilization target, or produce a return.
The right discussion starts after the seller understands the practice and equipment need, but before total price becomes the only frame for the decision. The representative can introduce an approved payment conversation, confirm buyer interest, and bring in LeasePoint for structure, application, credit, documentation, and transaction questions.
01
Replacement
A current device is being retired, upgraded, or exchanged.
02
Expansion
An operating practice is adding capacity or another modality.
03
New service line
The practice is entering a treatment category it does not currently offer.
04
New location
The equipment depends on a separate site, team, or opening plan.
05
Startup
The equipment is part of a new business with limited operating history.
05
Vendor discovery
What the vendor sales team should clarify
Better questions create a cleaner handoff without turning a representative into a credit expert.
- 01
What problem is the buyer trying to solve: replacement, capacity, new treatment, new site, or new practice?
- 02
Which device, applicators, software, accessories, training, warranty, and service are included?
- 03
Which costs sit outside the equipment quote?
- 04
Who will operate the equipment, and what credentials, training, or supervision are required?
- 05
What site work must be complete before delivery and installation?
- 06
Is the practice operating today, and how does the new service fit its current treatment mix?
- 07
What changes if installation, training, or opening moves later than planned?
- 08
Which demand, utilization, pricing, or revenue figures are buyer assumptions rather than verified results?
A responsible LeasePoint workflow
From equipment quote to financing support.
See how sellers, buyers, and LeasePoint work together from introduction through final requirements.
01
Frame the equipment decision
The seller captures the practice setting, purpose of the purchase, current quote, target timing, and known implementation needs.
02
Move the buyer into a secure experience
LeasePoint provides the appropriate application path and owns questions involving credit, possible structures, documentation, and next steps.
03
Coordinate permitted milestones
The vendor receives useful status and action requests according to its role, the buyer's consent, program design, and applicable agreements. Sensitive finance details remain with authorized parties.
07
Frequently asked questions
Questions that deserve a direct answer.
Focused guidance for sellers and buyers evaluating a complete equipment purchase.
What types of aesthetics equipment may be considered?+
Programs may be designed around lasers, energy-based platforms, body-contouring systems, skin technologies, imaging tools, and related practice equipment. Actual eligibility depends on the complete transaction, equipment, seller, buyer, structure, documentation, and applicable review.
When should a representative introduce financing?+
After the representative understands the equipment need and buyer context, but before full price becomes the only decision frame. The seller should use approved language and bring in LeasePoint rather than predict approval, terms, payment, timing, or business performance.
Can training, software, warranty, or service be included?+
They should appear clearly on the quote when they are part of the package. Whether a cost can be included is determined during the applicable financing review. The seller should also state who provides each item, when it begins, and what the buyer must do to keep coverage in force.
Does financing prove that a new treatment line will work?+
No. Financing addresses how an eligible purchase may be paid for. Patient demand, clinical results, utilization, pricing, revenue, profitability, and return remain separate business and clinical evaluations.
What happens if the equipment configuration changes?+
The revised quote should return through the approved workflow. Changes to equipment, amount, services, seller, location, ownership, or timing may require new review and updated documents.
Source register
Evidence behind the market context.
Research current through August 22, 2026. Statistics provide market context, not a forecast for an individual company, practice, project, or financing decision.